Comparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney disease.
作者信息
Shah Rashmee U, Chang Tara I, Fonarow Gregg C
机构信息
Cedars-Sinai Medical Center, Department of Cardiology, CA 90048, USA.
出版信息
Heart Fail Clin. 2013 Jan;9(1):79-92. doi: 10.1016/j.hfc.2012.09.003. Epub 2012 Oct 16.
Abstract
摘要
相似文献
1
Comparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney disease.
Heart Fail Clin. 2013 Jan;9(1):79-92. doi: 10.1016/j.hfc.2012.09.003. Epub 2012 Oct 16.
2
[Extrapolation of results from clinical trials to heart failure patients hospitalized in Internal Medicine].
Med Clin (Barc). 2014 May 20;142(10):463-7. doi: 10.1016/j.medcli.2013.06.011. Epub 2013 Sep 7.
3
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Am Heart J. 2007 Jun;153(6):1064-73. doi: 10.1016/j.ahj.2007.03.017.
4
Utilization of evidence-based treatment in elderly patients with chronic heart failure: using Korean Health Insurance claims database.
BMC Cardiovasc Disord. 2012 Jul 31;12:60. doi: 10.1186/1471-2261-12-60.
5
Comparative effectiveness research: drug-drug comparisons in heart failure.
Heart Fail Clin. 2013 Jan;9(1):37-47. doi: 10.1016/j.hfc.2012.09.008. Epub 2012 Oct 18.
6
[Cardio-geriatric polypragmatism. Pharmacotherapy in the elderly: "individual experiments"].
MMW Fortschr Med. 2005 Jun 9;147(23):8, 11.
7
Hypertensive therapy: Part II.
Circulation. 2004 Jun 29;109(25):3081-8. doi: 10.1161/01.CIR.0000132615.44103.B1.
8
J-curve phenomenon: a matter of debate.
Hellenic J Cardiol. 2012 Sep-Oct;53(5):357-66.
9
Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
Heart Fail Clin. 2013 Jan;9(1):59-77. doi: 10.1016/j.hfc.2012.09.006. Epub 2012 Oct 13.
10
Impact of comorbidity on medication use in elderly patients with cardiovascular diseases: the OCTOCARDIO study.
Eur J Prev Cardiol. 2013 Aug;20(4):524-30. doi: 10.1177/2047487312444235. Epub 2012 Mar 23.
引用本文的文献
1
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction.
Eur Heart J Qual Care Clin Outcomes. 2022 Oct 26;8(7):761-769. doi: 10.1093/ehjqcco/qcab070.
2
Capsule Commentary on Al-Khatib et al., Future Research Prioritization: Implantable Cardioverter Defibrillator Therapy in Older Patients.
J Gen Intern Med. 2015 Dec;30(12):1852. doi: 10.1007/s11606-015-3432-1.
3
Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.
Womens Health (Lond). 2015 Mar;11(2):239-257. doi: 10.2217/whe.14.64.
本文引用的文献
1
Eplerenone in patients with systolic heart failure and mild symptoms.
N Engl J Med. 2011 Jan 6;364(1):11-21. doi: 10.1056/NEJMoa1009492. Epub 2010 Nov 14.
2
Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial.
J Am Coll Cardiol. 2010 Nov 16;56(21):1701-8. doi: 10.1016/j.jacc.2010.03.105.
3
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.
Kidney Int. 2010 Oct;78(8):726-36. doi: 10.1038/ki.2010.292. Epub 2010 Aug 18.
4
Spironolactone use and renal toxicity: population based longitudinal analysis.
BMJ. 2010 May 18;340:c1768. doi: 10.1136/bmj.c1768.
5
Rationale and design of the beta-blocker in heart failure with normal left ventricular ejection fraction (beta-PRESERVE) study.
Eur J Heart Fail. 2010 Feb;12(2):181-5. doi: 10.1093/eurjhf/hfp193.
6
Heart disease and stroke statistics--2010 update: a report from the American Heart Association.
Circulation. 2010 Feb 23;121(7):e46-e215. doi: 10.1161/CIRCULATIONAHA.109.192667. Epub 2009 Dec 17.
7
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.
Lancet. 2009 Nov 28;374(9704):1840-8. doi: 10.1016/S0140-6736(09)61913-9. Epub 2009 Nov 16.
8
Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5.
9
Heart failure in women: epidemiology, biology and treatment.
Womens Health (Lond). 2009 Sep;5(5):517-27. doi: 10.2217/whe.09.50.
10
Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.
Eur J Heart Fail. 2009 Sep;11(9):872-80. doi: 10.1093/eurjhf/hfp104. Epub 2009 Aug 1.
Zotero 插件